Postmenopausal bone loss at multiple skeletal sites: relationship to estrogen use

Area of Science:

• Endocrinology
• Bone Biology
• Gerontology

Background:

• Osteoporosis is a significant health concern for postmenopausal women.
• Estrogen plays a critical role in bone health and metabolism.
• Understanding the long-term effects of estrogen replacement therapy (ERT) on bone density is vital.

Purpose of the Study:

• To investigate the relationship between estrogen use and bone mineral content (BMC) in postmenopausal women.
• To compare the effects of current versus prior estrogen use on bone density and fracture risk.
• To assess the impact of estrogen on both appendicular and axial bone sites.

Main Methods:

• Bone mineral content (BMC) was measured at the distal radius, proximal radius, and os calcis in 608 postmenopausal women.
• Radiographic assessment was used to determine vertebral osteoporosis and compression fractures.
• History of estrogen use (current vs. prior vs. non-users) was recorded and analyzed.

Main Results:

• Current estrogen users exhibited significantly higher BMC at all measured appendicular sites compared to non-users.
• Prior estrogen users showed higher appendicular BMC than non-users, though lower than current users.
• Current estrogen users had a significantly lower prevalence of spinal osteoporosis, while prior users did not differ from non-users.

Conclusions:

• Estrogen replacement therapy positively impacts bone mineral content in postmenopausal women.
• The bone-protective effects of estrogen on trabecular bone (os calcis) may be more transient than on cortical bone.
• Sustained or long-term estrogen replacement appears necessary for effective prevention of spinal compression fractures.